Anxiety is one of the most common and complex mental health disorders that affects millions of people worldwide. It could be episodic, and sometimes it may be overwhelming and make it difficult to ...

Generalized anxiety disorder affects millions, often trapping sufferers in cycles of fear and isolation that conventional ...

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial ...

People with anxiety disorders have lower levels of choline in their brains, according to research from UC Davis Health.

Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.

Credit: Getty Images. Lexapro is a selective serotonin reuptake inhibitor. The Food and Drug Administration (FDA) has approved Lexapro (escitalopram) for the treatment of generalized anxiety disorder ...

Scientists have identified a significant link between low levels of choline and the prevalence of anxiety disorders, ...

MARLBOROUGH, Mass. & PRINCETON, N.J.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) and Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) today announced that the first ...

Anxiety disorders are a group of disorders that share symptoms like excessive fear and heightened stress (American Psychological Association [APA], 2022). It is important to note that fear and anxiety ...

A study of individuals with generalized anxiety disorder in China found that they exhibit unusual patterns of affective inhibition and perform worse on tasks requiring affective shifting, compared to ...

-- Upsized Series A Financing Brings Total Amount Raised to $133 Million -- -- GAD Affects 3.1% of U.S. Adult Population; Minority of Patients Receive Treatment -- -- Reunion Expects to Initiate ...